⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PHAT News
Phathom Pharmaceuticals, Inc. Common Stock
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
globenewswire.com
PHAT
Phathom Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
PHAT
Phathom Pharmaceuticals Announces Publication of Data from Phase 3 pHalcon-NERD-301 Study Showing VOQUEZNA® (vonoprazan) Improved Nocturnal GERD Symptoms in Patients with Non-Erosive Reflux Disease
globenewswire.com
PHAT
Phathom Pharmaceuticals Appoints Sanjeev Narula as Chief Financial and Business Officer
globenewswire.com
PHAT